Chimeric Therapeutics Limited carries a market capitalization of 2.26M, placing it among publicly traded companies globally.
| Market Cap | 2.26M |
| Enterprise Value | N/A |
Chimeric Therapeutics Limited's stock has declined approximately -86.25% over the past 52 weeks. The 50-day moving average sits at 0.11, while the 200-day moving average is 0.22.
| Beta (5Y) | N/A |
| 52-Week Price Change | -86.25% |
| 50-Day Moving Average | 0.11 |
| 200-Day Moving Average | 0.22 |
| Average Volume (20 Days) | N/A |
Chimeric Therapeutics Limited's most recent stock split took place on April 22, 2026 with a 100:1 split ratio.
| Last Split Date | 4/22/2026 |
| Split Ratio | 100:1 |